These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
232 related items for PubMed ID: 12909621
1. Simultaneous binding of two different drugs in the binding pocket of the human multidrug resistance P-glycoprotein. Loo TW, Bartlett MC, Clarke DM. J Biol Chem; 2003 Oct 10; 278(41):39706-10. PubMed ID: 12909621 [Abstract] [Full Text] [Related]
2. Cross-linking of human multidrug resistance P-glycoprotein by the substrate, tris-(2-maleimidoethyl)amine, is altered by ATP hydrolysis. Evidence for rotation of a transmembrane helix. Loo TW, Clarke DM. J Biol Chem; 2001 Aug 24; 276(34):31800-5. PubMed ID: 11429407 [Abstract] [Full Text] [Related]
3. Substrate-induced conformational changes in the transmembrane segments of human P-glycoprotein. Direct evidence for the substrate-induced fit mechanism for drug binding. Loo TW, Bartlett MC, Clarke DM. J Biol Chem; 2003 Apr 18; 278(16):13603-6. PubMed ID: 12609990 [Abstract] [Full Text] [Related]
4. Methanethiosulfonate derivatives of rhodamine and verapamil activate human P-glycoprotein at different sites. Loo TW, Bartlett MC, Clarke DM. J Biol Chem; 2003 Dec 12; 278(50):50136-41. PubMed ID: 14522974 [Abstract] [Full Text] [Related]
5. Defining the drug-binding site in the human multidrug resistance P-glycoprotein using a methanethiosulfonate analog of verapamil, MTS-verapamil. Loo TW, Clarke DM. J Biol Chem; 2001 May 04; 276(18):14972-9. PubMed ID: 11279063 [Abstract] [Full Text] [Related]
6. Transmembrane segment 7 of human P-glycoprotein forms part of the drug-binding pocket. Loo TW, Bartlett MC, Clarke DM. Biochem J; 2006 Oct 15; 399(2):351-9. PubMed ID: 16813563 [Abstract] [Full Text] [Related]
7. Inhibition of oxidative cross-linking between engineered cysteine residues at positions 332 in predicted transmembrane segments (TM) 6 and 975 in predicted TM12 of human P-glycoprotein by drug substrates. Loo TW, Clarke DM. J Biol Chem; 1996 Nov 01; 271(44):27482-7. PubMed ID: 8910331 [Abstract] [Full Text] [Related]
8. Identification of residues in the drug-binding domain of human P-glycoprotein. Analysis of transmembrane segment 11 by cysteine-scanning mutagenesis and inhibition by dibromobimane. Loo TW, Clarke DM. J Biol Chem; 1999 Dec 10; 274(50):35388-92. PubMed ID: 10585407 [Abstract] [Full Text] [Related]
10. Permanent activation of the human P-glycoprotein by covalent modification of a residue in the drug-binding site. Loo TW, Bartlett MC, Clarke DM. J Biol Chem; 2003 Jun 06; 278(23):20449-52. PubMed ID: 12711602 [Abstract] [Full Text] [Related]
12. Location of the rhodamine-binding site in the human multidrug resistance P-glycoprotein. Loo TW, Clarke DM. J Biol Chem; 2002 Nov 15; 277(46):44332-8. PubMed ID: 12223492 [Abstract] [Full Text] [Related]
13. Drug-stimulated ATPase activity of human P-glycoprotein requires movement between transmembrane segments 6 and 12. Loo TW, Clarke DM. J Biol Chem; 1997 Aug 22; 272(34):20986-9. PubMed ID: 9261097 [Abstract] [Full Text] [Related]
14. Identification of residues in the drug translocation pathway of the human multidrug resistance P-glycoprotein by arginine mutagenesis. Loo TW, Bartlett MC, Clarke DM. J Biol Chem; 2009 Sep 04; 284(36):24074-87. PubMed ID: 19581304 [Abstract] [Full Text] [Related]
15. Disulfide cross-linking analysis shows that transmembrane segments 5 and 8 of human P-glycoprotein are close together on the cytoplasmic side of the membrane. Loo TW, Bartlett MC, Clarke DM. J Biol Chem; 2004 Feb 27; 279(9):7692-7. PubMed ID: 14670948 [Abstract] [Full Text] [Related]
18. Introduction of the most common cystic fibrosis mutation (Delta F508) into human P-glycoprotein disrupts packing of the transmembrane segments. Loo TW, Bartlett MC, Clarke DM. J Biol Chem; 2002 Aug 02; 277(31):27585-8. PubMed ID: 12070134 [Abstract] [Full Text] [Related]